From: Male breast cancer: a report of 127 cases at a Moroccan institution
 | 0- 49 | 20 cases | 16% |
 | 50-59 | 35 | 27,5% |
Age (years) | 60-69 | 50 | 39% |
 | > 70 | 22 | 17,5% |
 | Mass beneath the areola | 119 cases | 93,5% |
Clinical complaint | Gynecomastia | 5 | 4% |
 | Paget'disease | 3 | 2,5% |
 | Tx | 2 cases | 1,5% |
 | T1 | 6 | 5% |
Primary Tumor | T2 | 18 | 14% |
 | T3 | 22 | 17% |
 | T4 | 79 | 62,5% |
 | Nx | 9 | 7,1% |
Lymph node | N0 | 16 | 12,5% |
 | N1 | 70 | 55,2% |
 | N2 | 32 | 25,2% |
Metastasis | M0 | 90 | 71% |
 | M1 | 37 | 29% |
 | I | 6 | 5% |
 | IIA | 8 | 6,1 |
Stage | IIB | 12 | 9,6 |
 | III | 64 | 50,3% |
 | IV | 37 | 29% |
 | IDC: | 122 | 96% |
 | SBR 2 ou 3 | 100 | 82% |
Histology | With Paget's disaese | 2 | 1,6% |
 | ILC | 1 | 0,8% |
 | ND | 2 | 1,6% |
Lymph node status | pN0 | 29 | 35,5% |
 | pN+ | 54 | 64,5% |
Hormone receptors | RE | 39/61 | 64% |
 | RP | 39/61 | 64% |